Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan versus omeprazole in quadruple therapy for Helicobacter pylori infection
IRCT20250824066979N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of vonoprazan and omeprazole in Helicobacter pylori infection (2 arms), sponsored by Islamic Azad University. Primary endpoints: Improvement of disease symptoms, Improvement of side effects from the quadruple therapy drugs and 1 more. Started Jul 2026; status: completed.
02
Drugs
vonoprazanomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20250824066979N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250824066979N1.